STAR
Introduction
STAR Background
STAR-At-A Glance
STAR Enrollment Statistics
STAR
Images
STAR
Participant Advisory Board (PAB)
STAR
Publications
STAR Result Images
STAR Q and A |
The following links will take you
to press releases and other materials concerning the
STAR trial that have been prepared by the National Cancer
Institute's Office of Communications.
Initial Results of the Study of Tamoxifen and Raloxifene
(STAR) Released: Osteoporosis Drug Raloxifene Shown
to be as Effective as Tamoxifen in Preventing Invasive
Breast Cancer
(Posted: 04/17/2006) - Initial results of the Study
of Tamoxifen and Raloxifene, or STAR, show that the
drug raloxifene, currently used to prevent and treat
osteoporosis in postmenopausal women, works as well
as tamoxifen in reducing breast cancer risk for postmenopausal
women at increased risk of the disease. Questions
and Answers
Major
Breast Cancer Prevention Study Enters Final Stretch
An article from the March 9, 2004, issue of the NCI
Cancer Bulletin.
|
